VivoSim Labs Inc Sustainability Reports
VivoSim Labs, Inc. designs and develops functional, three-dimensional human tissue models of the liver and intestine for preclinical toxicology screening and drug development research. The company utilizes primary human cells to build micro-organoid structures that emulate native human biology to evaluate safety and efficacy without relying entirely on animal testing.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001V10TP9
1 reports from 2025 to 2025